Ellipses

Ellipses Pharma is a precision drug development company focused on oncology, dedicated to accelerating the advancement of cancer medicines and treatments. Founded by Professor Sir Chris Evans, one of Europe’s leading scientific entrepreneurs and the founder of the Cancer Awareness Trust, Ellipses aims to streamline the clinical trials process, which has become overly complex and costly, in order to speed up the development of new treatments.

With a scalable business model, Ellipses runs multiple oncology trials in parallel, ensuring a continuous source of capital for cancer drug development. Supported by top oncologists, the company is taking an ambitious approach to make a significant impact on the cancer drug development landscape, while also driving forward the development of Cancer Platform through the Cancer Awareness Trust.